SURAKSHA DIAGNOSTIC
Back to Cashflow Statement
|
SURAKSHA DIAGNOSTIC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-29 Cr | ₹-24 Cr | ₹-25 Cr | ₹-24 Cr | ₹1.09 Cr |
What is the latest Cash Flow from Financing Activities ratio of SURAKSHA DIAGNOSTIC ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-29 Cr |
| Mar2025 | ₹-24 Cr |
| Mar2024 | ₹-25 Cr |
| Mar2023 | ₹-24 Cr |
| Mar2022 | ₹1.09 Cr |
How is Cash Flow from Financing Activities of SURAKSHA DIAGNOSTIC Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-29 Cr | Negative | |
| Mar2025 | ₹-24 Cr | Negative | |
| Mar2024 | ₹-25 Cr | Negative | |
| Mar2023 | ₹-24 Cr | Negative | |
| Mar2022 | ₹1.09 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SURAKSHA DIAGNOSTIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SURAKSHA DIAGNOSTIC | ₹1,750.8 Cr | 3.7% | 7.9% | 6.3% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹126,103.0 Cr | -0.9% | -0.3% | 11.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹102,684.0 Cr | 1.7% | 5.9% | -12.7% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹66,058.8 Cr | -1.4% | -3.9% | -8.5% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹65,885.4 Cr | -0.9% | -5.6% | 20.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹39,436.5 Cr | 3.3% | 8.3% | 6.1% | Stock Analytics | |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SURAKSHA DIAGNOSTIC | 3.7% |
7.9% |
6.3% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses